Potential of rat bone marrow-derived mesenchymal stem cells as vehicles for delivery of neurotrophins to the Parkinsonian rat brain

Brain Research

Volumn 1359, Issue , 2010, Pages 33-43

  Moloney, Teresa C ^a   Rooney, Gemma E ^a   Barry, Frank P ^a   Howard, Linda ^a   Dowd, Eilís ^a  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

Author keywords

6 hydroxydopamine; GDNF; Mesenchymal stem cells; Neuroprotection; Parkinson's disease

Indexed keywords

GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; OXIDOPAMINE; TYROSINE 3 MONOOXYGENASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW; CORPUS STRIATUM; EX VIVO GENE TRANSFER; IMMUNOHISTOCHEMISTRY; MALE; MESENCHYMAL STEM CELL; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; VIRAL GENE DELIVERY SYSTEM;

ANIMALS; BONE MARROW CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE THERAPY; GENE TRANSFER TECHNIQUES; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; IMMUNOHISTOCHEMISTRY; MALE; MESENCHYMAL STEM CELLS; NERVE GROWTH FACTORS; PARKINSON DISEASE; RATS; RATS, SPRAGUE-DAWLEY; TRANSDUCTION, GENETIC;

PARKINSONIA; RATTUS;

EID: 77957986219     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2010.08.040     Document Type: Article

References (45)

1. O.Y. Bang, J.S. Lee, P.H. Lee, and G. Lee Autologous mesenchymal stem cell transplantation in stroke patients Ann. Neurol. 57 2005 874 882
2. A. Bartholomew, C. Sturgeon, M. Siatskas, K. Ferrer, K. McIntosh, S. Patil, W. Hardy, S. Devine, D. Ucker, R. Deans, A. Moseley, and R. Hoffman Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo Exp. Hematol. 30 2002 42 48
3. C. Bartmann, E. Rohde, K. Schallmoser, P. Purstner, G. Lanzer, W. Linkesch, and D. Strunk Two steps to functional mesenchymal stromal cells for clinical application Transfusion 47 2007 1426 1435
4. K.D. Beck, J. Valverde, T. Alexi, K. Poulsen, B. Moffat, R.A. Vandlen, A. Rosenthal, and F. Hefti Mesencephalic dopaminergic neurons protected by GDNF from axotomy-induced degeneration in the adult brain Nature 373 1995 339 341
5. G. Bouchez, L. Sensebe, P. Vourc'h, L. Garreau, S. Bodard, A. Rico, D. Guilloteau, P. Charbord, J.C. Besnard, and S. Chalon Partial recovery of dopaminergic pathway after graft of adult mesenchymal stem cells in a rat model of Parkinson's disease Neurochem. Int. 52 2008 1332 1342
6. D.M. Camp, D.A. Loeffler, D.M. Farrah, J.N. Borneman, and P.A. LeWitt Cellular immune response to intrastriatally implanted allogeneic bone marrow stromal cells in a rat model of Parkinson's disease J. Neuroinflammation 6 2009 17
7. M.A. Cenci L-DOPA-induced dyskinesia: cellular mechanisms and approaches to treatment Parkinsonism Relat. Disord. 13 Suppl 3 2007 S263 S267
8. Y.X. Chao, B.P. He, and S.S. Tay Mesenchymal stem cell transplantation attenuates blood brain barrier damage and neuroinflammation and protects dopaminergic neurons against MPTP toxicity in the substantia nigra in a model of Parkinson's disease J. Neuroimmunol. 216 2009 39 50
9. L. Cova, M.T. Armentero, E. Zennaro, C. Calzarossa, P. Bossolasco, G. Busca, G. Lambertenghi Deliliers, E. Polli, G. Nappi, V. Silani, and F. Blandini Multiple neurogenic and neurorescue effects of human mesenchymal stem cell after transplantation in an experimental model of Parkinson's disease Brain Res. 1311 2010 12 27
10. C.M. Digirolamo, D. Stokes, D. Colter, D.G. Phinney, R. Class, and D.J. Prockop Propagation and senescence of human marrow stromal cells in culture: a simple colony-forming assay identifies samples with the greatest potential to propagate and differentiate Br. J. Haematol. 107 1999 275 281
11. M. Di Nicola, C. Carlo-Stella, M. Magni, M. Milanesi, P.D. Longoni, P. Matteucci, S. Grisanti, and A.M. Gianni Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli Blood 99 2002 3838 3843
12. E. Dowd, C. Monville, E.M. Torres, and S.B. Dunnett The Corridor Task: a simple test of lateralised response selection sensitive to unilateral dopamine deafferentation and graft-derived dopamine replacement in the striatum Brain Res. Bull. 68 2005 24 30
13. S.S. Gill, N.K. Patel, G.R. Hotton, K. O'Sullivan, R. McCarter, M. Bunnage, D.J. Brooks, C.N. Svendsen, and P. Heywood Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease Nat. Med. 9 2003 589 595
14. W. Gu, F. Zhang, Q. Xue, Z. Ma, P. Lu, and B. Yu Transplantation of bone marrow mesenchymal stem cells reduces lesion volume and induces axonal regrowth of injured spinal cord Neuropathology 30 2010 205 217
15. T. Ito, A. Suzuki, E. Imai, M. Okabe, and M. Hori Bone marrow is a reservoir of repopulating mesangial cells during glomerular remodeling J. Am. Soc. Nephrol. 12 2001 2625 2635 (Pubitemid 33115409)
16. C.M. Kearns, W.A. Cass, K. Smoot, R. Kryscio, and D.M. Gash GDNF protection against 6-OHDA: time dependence and requirement for protein synthesis J. Neurosci. 17 1997 7111 7118
17. D. Kirik, C. Rosenblad, and A. Bjorklund Characterization of behavioral and neurodegenerative changes following partial lesions of the nigrostriatal dopamine system induced by intrastriatal 6-hydroxydopamine in the rat Exp. Neurol. 152 1998 259 277
18. D. Kirik, C. Rosenblad, and A. Bjorklund Preservation of a functional nigrostriatal dopamine pathway by GDNF in the intrastriatal 6-OHDA lesion model depends on the site of administration of the trophic factor Eur. J. Neurosci. 12 2000 3871 3882
19. K. Kurozumi, K. Nakamura, T. Tamiya, Y. Kawano, K. Ishii, M. Kobune, S. Hirai, H. Uchida, K. Sasaki, Y. Ito, K. Kato, O. Honmou, K. Houkin, I. Date, and H. Hamada Mesenchymal stem cells that produce neurotrophic factors reduce ischemic damage in the rat middle cerebral artery occlusion model Mol. Ther. 11 2005 96 104
20. A.E. Lang, and A.M. Lozano Parkinson's disease. First of two parts N Engl J. Med. 339 1998 1044 1053
21. A.E. Lang, S. Gill, N.K. Patel, A. Lozano, J.G. Nutt, R. Penn, D.J. Brooks, G. Hotton, E. Moro, P. Heywood, M.A. Brodsky, K. Burchiel, P. Kelly, A. Dalvi, B. Scott, M. Stacy, D. Turner, V.G. Wooten, W.J. Elias, E.R. Laws, V. Dhawan, A.J. Stoessl, J. Matcham, R.J. Coffey, and M. Traub Randomized controlled trial of intraputamenal glial cell line-derived neurotrophic factor infusion in Parkinson disease Ann. Neurol. 59 2006 459 466
22. P.H. Lee, J.W. Kim, O.Y. Bang, Y.H. Ahn, I.S. Joo, and K. Huh Autologous mesenchymal stem cell therapy delays the progression of neurological deficits in patients with multiple system atrophy Clin. Pharmacol. Ther. 83 2008 723 730
23. L.F. Lin, D.H. Doherty, J.D. Lile, S. Bektesh, and F. Collins GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons Science 260 1993 1130 1132
24. S. Love, P. Plaha, N.K. Patel, G.R. Hotton, D.J. Brooks, and S.S. Gill Glial cell line-derived neurotrophic factor induces neuronal sprouting in human brain Nat. Med. 11 2005 703 704
25. T.C. Moloney, P. Dockery, A.J. Windebank, P.B. Barry, L. Howard, and E. Dowd Survival and immunogenicity of mesenchymal stem cells from the green fluorescent protein transgenic rat in the adult rat brain Neurorehab. Neural Res. 2010 10.1177/1545968309357745
26. H. Ohtaki, J.H. Ylostalo, J.E. Foraker, A.P. Robinson, R.L. Reger, S. Shioda, and D.J. Prockop Stem/progenitor cells from bone marrow decrease neuronal death in global ischemia by modulation of inflammatory/immune responses Proc. Natl Acad. Sci. USA 105 2008 14638 14643
27. M. Okabe, M. Ikawa, K. Kominami, T. Nakanishi, and Y. Nishimune 'Green mice' as a source of ubiquitous green cells FEBS Lett. 407 1997 313 319
28. M. Olsson, G. Nikkhah, C. Bentlage, and A. Bjorklund Forelimb akinesia in the rat Parkinson model: differential effects of dopamine agonists and nigral transplants as assessed by a new stepping test J. Neurosci. 15 1995 3863 3875
29. A.M. Parr, I. Kulbatski, T. Zahir, X. Wang, C. Yue, A. Keating, and C.H. Tator Transplanted adult spinal cord-derived neural stem/progenitor cells promote early functional recovery after rat spinal cord injury Neuroscience 155 2008 760 770
30. M.F. Pittenger, A.M. Mackay, S.C. Beck, R.K. Jaiswal, R. Douglas, J.D. Mosca, M.A. Moorman, D.W. Simonetti, S. Craig, and D.R. Marshak Multilineage potential of adult human mesenchymal stem cells Science 284 1999 143 147
31. G.E. Rooney, C. Moran, S.S. McMahon, T. Ritter, M. Maenz, A. Flugel, P. Dockery, T. O'Brien, L. Howard, A.J. Windebank, and F.P. Barry Gene-modified mesenchymal stem cells express functionally active nerve growth factor on an engineered poly lactic glycolic acid (PLGA) substrate Tissue Eng. A 14 2008 681 690
32. G.E. Rooney, S.S. McMahon, T. Ritter, Y. Garcia, C. Moran, N.N. Madigan, A. Flugel, P. Dockery, T. O'Brien, L. Howard, A.J. Windebank, and F.P. Barry Neurotrophic factor-expressing mesenchymal stem cells survive transplantation into the contused spinal cord without differentiating into neural cells Tissue Eng. A 15 2009 3049 3059
33. C. Rosenblad, A. Martinez-Serrano, and A. Bjorklund Intrastriatal glial cell line-derived neurotrophic factor promotes sprouting of spared nigrostriatal dopaminergic afferents and induces recovery of function in a rat model of Parkinson's disease Neuroscience 82 1998 129 137
34. C. Rosenblad, D. Kirik, B. Devaux, B. Moffat, H.S. Phillips, and A. Bjorklund Protection and regeneration of nigral dopaminergic neurons by neurturin or GDNF in a partial lesion model of Parkinson's disease after administration into the striatum or the lateral ventricle Eur. J. Neurosci. 11 1999 1554 1566
35. C. Rosenblad, D. Kirik, and A. Bjorklund Sequential administration of GDNF into the substantia nigra and striatum promotes dopamine neuron survival and axonal sprouting but not striatal reinnervation or functional recovery in the partial 6-OHDA lesion model Exp. Neurol. 161 2000 503 516
36. J. Rossignol, C. Boyer, R. Thinard, S. Remy, A.S. Dugast, D. Dubayle, N.D. Dey, F. Boeffard, J. Delecrin, D. Heymann, B. Vanhove, I. Anegon, P. Naveilhan, G.L. Dunbar, and L. Lescaudron Mesenchymal stem cells induce a weak immune response in the rat striatum after allo or xenotransplantation J. Cell. Mol. Med. 13 2009 2547 2558
37. T.B. Sherer, B.K. Fiske, C.N. Svendsen, A.E. Lang, and J.W. Langston Crossroads in GDNF therapy for Parkinson's disease Mov. Disord. 21 2006 136 141
38. J.T. Slevin, G.A. Gerhardt, C.D. Smith, D.M. Gash, R. Kryscio, and B. Young Improvement of bilateral motor functions in patients with Parkinson disease through the unilateral intraputaminal infusion of glial cell line-derived neurotrophic factor J. Neurosurg. 102 2005 216 222
39. A.M. Sullivan, J. Opacka-Juffry, and S.B. Blunt Long-term protection of the rat nigrostriatal dopaminergic system by glial cell line-derived neurotrophic factor against 6-hydroxydopamine in vivo Eur. J. Neurosci. 10 1998 57 63
40. E.M. Torres, C. Monville, M.A. Gates, V. Bagga, and S.B. Dunnett Improved survival of young donor age dopamine grafts in a rat model of Parkinson's disease Neuroscience 146 2007 1606 1617
41. U. Ungerstedt, and G.W. Arbuthnott Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system Brain Res. 24 1970 485 493
42. N.K. Venkataramana, S.K. Kumar, S. Balaraju, R.C. Radhakrishnan, A. Bansal, A. Dixit, D.K. Rao, M. Das, M. Jan, P.K. Gupta, and S.M. Totey Open-labeled study of unilateral autologous bone-marrow-derived mesenchymal stem cell transplantation in Parkinson's disease Transl. Res. 155 2010 62 70
43. C. Winkler, H. Sauer, C.S. Lee, and A. Bjorklund Short-term GDNF treatment provides long-term rescue of lesioned nigral dopaminergic neurons in a rat model of Parkinson's disease J. Neurosci. 16 1996 7206 7215
44. M. Ye, X.J. Wang, Y.H. Zhang, G.Q. Lu, L. Liang, J.Y. Xu, and C. Sheng-Di Therapeutic effects of differentiated bone marrow stromal cell transplantation on rat models of Parkinson's disease Parkinsonism Relat. Disord. 13 2007 44 49 (Pubitemid 46157203)
45. Z. Zhang, X. Wang, and S. Wang Isolation and characterization of mesenchymal stem cells derived from bone marrow of patients with Parkinson's disease In Vitro Cell. Dev. Biol. Anim. 44 2008 169 177